Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Clinical trial NCT00039325 · COMPLETED

Trial details

NCT number: NCT00039325
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2002-03-01
Primary completion: 2005-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.